Jonathan Lischalk, MD

Dr. Lischalk is a board-certified radiation oncologist with extensive experience in stereotactic radiosurgery, SBRT, intensity modulated radiation therapy, and proton beam therapy. In addition to his positions as clinical director of the radiosurgery service and specialty service director of the Genitourinary Cancer Program at Georgetown, he serves as assistant director of the clinical trials office at Georgetown Lombardi Comprehensive Cancer Center, vice-chief of clinical research for Medstar Radiation Oncology, and is a clinical associate professor at the Georgetown University School of Medicine.

Before joining MedStar Georgetown, Dr. Lischalk held several leadership positions at New York University Perlmutter Cancer Center, where he served as medical director of the NYU CyberKnife Center, director of research for the NYU-LI Department of Radiation Oncology, and clinical associate professor in the NYU-LI Grossman School of Medicine. He also previously served as director of thoracic radiation oncology at Georgetown University Hospital.

Dr. Lischalk earned his medical doctorate from the University of Washington School of Medicine. He completed his internship in internal medicine at Stamford/Columbia University College of Physicians and Surgeons, followed by his residency and chief residency at Georgetown University Hospital.

Dr. Lischalk’s clinical research focuses on genitourinary, thoracic, and central nervous system cancers, with particular expertise in innovative approaches to prostate cancer treatment, including MRI-directed SBRT microboost techniques and the integration of advanced technologies for precision treatment delivery. He has been at the forefront of developing clinical trials and has led several successful investigator initiated trials for novel treatments of prostate and lung cancers.

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none